Literature DB >> 24795020

LXR agonism inhibits metastatic melanoma through activation of ApoE.

.   

Abstract

Nuclear hormone receptor targeting suppresses melanoma progression in diverse preclinical models.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24795020     DOI： 10.1158/2159-8290.CD-RW2014-056

Source DB:  PubMed          Journal:  Cancer Discov        ISSN： 2159-8274            Impact factor:   39.397


  3 in total

Review 1.  Nuclear receptors in cancer - uncovering new and evolving roles through genomic analysis.

Authors:  Vineet K Dhiman; Michael J Bolt; Kevin P White
Journal:  Nat Rev Genet       Date:  2017-12-27       Impact factor: 53.242

Review 2.  Targeting the tumor microenvironment in cholangiocarcinoma: implications for therapy.

Authors:  Juan Wang; Sumera Ilyas
Journal:  Expert Opin Investig Drugs       Date:  2020-12-28       Impact factor: 6.206

3.  Integrated bioinformatics analysis of the association between apolipoprotein E expression and patient prognosis in papillary thyroid carcinoma.

Authors:  Qunguang Jiang; Wenqian Feng; Chengfeng Xiong; Yunxia Lv
Journal:  Oncol Lett       Date:  2020-01-17       Impact factor: 2.967
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.